← Leaderboards
Marsha L Davenport
University Of North Carolina Chapel Hill
$2,251,570
Attributed
$2,251,570
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $12K · FY2007–08$20K$15K$10K$5K$0
'07
'08
Funding mix
By agency
NIH$2,251,570 · 7
By mechanism
M01$2,240,836 · 5
P51$10,734 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Steven Nmn Offenbacher$19,026,540
- David J Zajac$9,473,318
- Patricia F Maness$8,998,686
- Vangie A Foshee$2,650,252
- David Robert Clemmons$15,091,383
Others in their field
Top investigators on “Hormone Therapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,218,842
- Norman Wolmark · Nsabp Foundation, Inc.$52,116,546
- Richard L Schilsky · University Of Chicago$50,338,295
- Mardge H Cohen · Hektoen Institute For Medical Research$40,843,261
Research focus
Hormone TherapyHuman SubjectClinical ResearchHuman Therapy EvaluationSomatotropinChild Physical DevelopmentTurner'S SyndromeClinical TrialsInsulinAdult Human (21+)Orthodontic AppliancesCase HistoryChemopreventionChild (0-11)Social BehaviorPrediabetic StateFamily GeneticsPrognosisPancreatic Islet FunctionCraniofacialDiabetes Mellitus TherapyInsulin Dependent Diabetes MellitusDisease /Disorder Proneness /RiskPlastic Surgery
Grant awards (23)
CLINICAL TRIAL: EFFECT OF EARLY GROWTH HORMONE TREATMENT ON LONG-TERM SKELETAL M$689
M01 · FY2008 · RR · contact PI
ESTABLISHING PREDICTORS OF SELF INJURIOUS BEHAVIOR IN RHESUS MONKEYS$5,367
P51 · FY2007 · RR · contact PI
EFFECT OF RELOCATION ON NIGHTTIME ACTIVITY AND STRESS RESPONSES IN MACAQUES$5,367
P51 · FY2007 · RR · contact PI
EFFECT OF EARLY GROWTH HORMONE TREATMENT ON LONG-TERM SKELETAL MATURATION$1,313
M01 · FY2007 · RR · contact PI
Effect of Hormone Treatment on Growth of Infants &Toddlers with Turner Syndrome$2,830
M01 · FY2004 · RR
DIABETES PREVENTION TRIAL OF TYPE I DIABETES$190,747
M01 · FY2002 · RR
ORTHODONTIC &RECONSTRUCTIVE SURGERY NEEDS IN TURNER SYNDROME PATIENTS ON GH$190,747
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL OF TYPE I DIABETES$294,555
M01 · FY2001 · RR
ORTHODONTIC &RECONSTRUCTIVE SURGERY NEEDS IN TURNER SYNDROME PATIENTS ON GH$294,555
M01 · FY2001 · RR
ORTHODONTIC &RECONSTRUCTIVE SURGERY NEEDS IN TURNER SYNDROME PATIENTS ON GH$190,747
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL OF TYPE I DIABETES$190,747
M01 · FY2001 · RR
ORTHODONTIC &RECONSTRUCTIVE SURGERY NEEDS IN TURNER SYNDROME PATIENTS ON GH$294,555
M01 · FY2000 · RR
ORTHODONTIC &RECONSTRUCTIVE SURGERY NEEDS IN TURNER SYNDROME PATIENTS ON GH$294,555
M01 · FY2000 · RR
ORTHODONTIC &RECONSTRUCTIVE SURGERY NEEDS IN TURNER SYNDROME PATIENTS ON GH$294,555
M01 · FY2000 · RR
ORTHODONTIC &RECONSTRUCTIVE SURGERY NEEDS IN TURNER SYNDROME PATIENTS ON GH$241
M01 · FY2000 · RR
RECOMBINANT HUMAN GROWTH HORMONE IN TURNER SYNDROME$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL OF TYPE I DIABETES (DPT-I)$0
M01 · FY2000 · RR
RECOMBINANT HUMAN GROWTH HORMONE IN TURNER SYNDROME$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL OF TYPE I DIABETES (DPT-I)$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL OF TYPE I DIABETES (DPT-I)$0
M01 · FY2000 · RR
RECOMBINANT HUMAN GROWTH HORMONE IN TURNER SYNDROME$0
M01 · FY2000 · RR
RECOMBINANT HUMAN GROWTH HORMONE IN TURNER SYNDROME$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL OF TYPE I DIABETES (DPT-I)$0
M01 · FY2000 · RR